Naoki Itabashi

1.1k total citations
18 papers, 328 citations indexed

About

Naoki Itabashi is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Naoki Itabashi has authored 18 papers receiving a total of 328 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Endocrinology, Diabetes and Metabolism and 6 papers in Surgery. Recurrent topics in Naoki Itabashi's work include Hormonal Regulation and Hypertension (5 papers), Sodium Intake and Health (3 papers) and Blood Pressure and Hypertension Studies (3 papers). Naoki Itabashi is often cited by papers focused on Hormonal Regulation and Hypertension (5 papers), Sodium Intake and Health (3 papers) and Blood Pressure and Hypertension Studies (3 papers). Naoki Itabashi collaborates with scholars based in Japan and Australia. Naoki Itabashi's co-authors include Shun Ishibashi, Koji Okada, Nobuya Fujita, Genro Fujisawa, Shigeaki Muto, Eiji Kusano, Hiroyuki Ohbayashi, Kazuomi Kario, Yusuke Furukawa and Toshikazu Saito and has published in prestigious journals such as Kidney International, Hypertension and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Naoki Itabashi

17 papers receiving 323 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Naoki Itabashi Japan 7 202 112 104 87 47 18 328
Emily J. Johnson United States 8 179 0.9× 60 0.5× 134 1.3× 93 1.1× 102 2.2× 10 398
Kumiko Kaifu Japan 12 194 1.0× 118 1.1× 88 0.8× 86 1.0× 81 1.7× 15 426
Bruno Sevá Pessôa Netherlands 7 104 0.5× 143 1.3× 100 1.0× 38 0.4× 24 0.5× 8 322
Chien‐Ting Pan Taiwan 12 320 1.6× 113 1.0× 69 0.7× 258 3.0× 82 1.7× 29 490
Naoto Terami Japan 5 248 1.2× 31 0.3× 116 1.1× 124 1.4× 110 2.3× 5 365
Shigefumi Nakano Japan 7 155 0.8× 116 1.0× 104 1.0× 92 1.1× 24 0.5× 9 341
Daishiro Yamada Japan 12 241 1.2× 129 1.2× 206 2.0× 67 0.8× 133 2.8× 17 541
S. Crowe Germany 6 396 2.0× 123 1.1× 170 1.6× 159 1.8× 35 0.7× 16 461
Maria G. Dekker Canada 9 201 1.0× 134 1.2× 70 0.7× 65 0.7× 239 5.1× 9 474
Diego Scerbo United States 9 135 0.7× 60 0.5× 196 1.9× 77 0.9× 25 0.5× 11 392

Countries citing papers authored by Naoki Itabashi

Since Specialization
Citations

This map shows the geographic impact of Naoki Itabashi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naoki Itabashi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naoki Itabashi more than expected).

Fields of papers citing papers by Naoki Itabashi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naoki Itabashi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naoki Itabashi. The network helps show where Naoki Itabashi may publish in the future.

Co-authorship network of co-authors of Naoki Itabashi

This figure shows the co-authorship network connecting the top 25 collaborators of Naoki Itabashi. A scholar is included among the top collaborators of Naoki Itabashi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naoki Itabashi. Naoki Itabashi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Tanabe, Katsuyuki, Tomokazu Nunoue, Naoki Itabashi, et al.. (2025). Dotinurad Treatment for Patients With Hyperuricemia Complicating CKD. Kidney International Reports. 10(6). 1711–1720. 4 indexed citations
2.
Kario, Kazuomi, Hiroyuki Ohbayashi, Naoki Itabashi, et al.. (2025). Home blood pressure-lowering effect of esaxerenone vs trichlormethiazide for uncontrolled hypertension: a prespecified subanalysis of the EXCITE-HT randomized controlled study by age subgroup. Hypertension Research. 48(4). 1586–1598. 2 indexed citations
3.
4.
5.
6.
Itabashi, Naoki, et al.. (2023). System for the Synchronisation of Position, Motion and Audio Between MR and VR. 276–280. 1 indexed citations
7.
Itabashi, Naoki, et al.. (2023). Mixed Reality Guided Museum Tour: Digital Enhancement of Museum Experience. 809–810. 3 indexed citations
8.
Kario, Kazuomi, Satoshi Hoshide, Yukie Okawara, et al.. (2018). Effect of canagliflozin on nocturnal home blood pressure in Japanese patients with type 2 diabetes mellitus: The SHIFT‐J study. Journal of Clinical Hypertension. 20(10). 1527–1535. 32 indexed citations
9.
Yagyu, Hiroaki, Naoki Itabashi, Fumiko Tazoe, et al.. (2008). Cholesterol Reduction and Atherosclerosis Inhibition by Bezafibrate in Low-Density Lipoprotein Receptor Knockout Mice. Hypertension Research. 31(5). 999–1005. 6 indexed citations
10.
Shinozaki, Satoshi, Naoki Itabashi, Shoichiro Nagasaka, et al.. (2005). Diabetic lipemia with eruptive xanthomatosis in a lean young female with apolipoprotein E4/4. Diabetes Research and Clinical Practice. 70(2). 183–192. 7 indexed citations
11.
Fujisawa, Genro, Koji Okada, Shigeaki Muto, et al.. (2004). Spironolactone prevents early renal injury in streptozotocin-induced diabetic rats. Kidney International. 66(4). 1493–1502. 153 indexed citations
12.
Ogura, Manabu, Ikuyo Kusaka, Shoichiro Nagasaka, et al.. (2003). Unilateral Adrenalectomy Improves Insulin Resistance and Diabetes Mellitus in a Patient with ACTH-Independent Macronodular Adrenal Hyperplasia. Endocrine Journal. 50(6). 715–721. 24 indexed citations
13.
Fujisawa, Genro, Koji Okada, Shigeaki Muto, et al.. (2003). Na/H Exchange Isoform 1 Is Involved in Mineralocorticoid/Salt-Induced Cardiac Injury. Hypertension. 41(3). 493–498. 42 indexed citations
14.
Fujita, Nobuya, Yusuke Furukawa, Jian Du, et al.. (2002). Hyperglycemia enhances VSMC proliferation with NF-κB activation by angiotensin II and E2F-1 augmentation by growth factors. Molecular and Cellular Endocrinology. 192(1-2). 75–84. 20 indexed citations
15.
Fujita, Nobuya, Yusuke Furukawa, Naoki Itabashi, et al.. (2002). Differences in E2F subunit expression in quiescent and proliferating vascular smooth muscle cells. American Journal of Physiology-Heart and Circulatory Physiology. 283(1). H204–H212. 6 indexed citations
16.
Itabashi, Naoki, Koji Okada, Shigeaki Muto, et al.. (2001). A Novel Enhancer of Insulinotrophic Action by High Glucose (JTT-608) Stimulates Insulin Secretion from Pancreatic β-Cells via a New Cellular Mechanism. Journal of Pharmacology and Experimental Therapeutics. 297(3). 953–960. 2 indexed citations
17.
Itabashi, Naoki, Koji Okada, Naruhiro Fujita, et al.. (2001). A novel enhancer of insulinotrophic action by high glucose (JTT-608) stimulates insulin secretion from pancreatic beta-cells via a new cellular mechanism.. PubMed. 297(3). 953–60. 5 indexed citations
18.
Fujita, Nobuya, Yusuke Furukawa, Naoki Itabashi, et al.. (1999). Failure of cdc2 promoter activation and G2/M transition by ANG II and AVP in vascular smooth muscle cells. American Journal of Physiology-Heart and Circulatory Physiology. 277(2). H515–H523. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Emily J. Johnson Breakdown of academic impact, for papers by Kumiko Kaifu Breakdown of academic impact, for papers by Bruno Sevá Pessôa Breakdown of academic impact, for papers by Chien‐Ting Pan Breakdown of academic impact, for papers by Naoto Terami Breakdown of academic impact, for papers by Shigefumi Nakano Breakdown of academic impact, for papers by Daishiro Yamada Breakdown of academic impact, for papers by S. Crowe Breakdown of academic impact, for papers by Maria G. Dekker Breakdown of academic impact, for papers by Diego Scerbo
Rankless by CCL
2026